A class action on behalf of investors in Valeant Pharmaceuticals International, Inc. (“Valeant”) (TSX and NYSE: “VRX”) will proceed toward trial now that Québec’s Court of Appeal has dismissed applications by the defendants to commence an appeal from the judgment of the Honourable Justice Chantal Chatelain of the Québec Superior Court, dated August 29, 2017, which authorized the securities class action. Please click here for the Press Release. A copy of the judgment can be viewed here.
Deprecated: category_link is deprecated since version 2.5.0! Use term_link instead. in /var/www/wp-includes/functions.php on line 5089